Dr Reddy's gets extra time to respond to warning letter

Earlier this month, the US health regulator has issued a warning letter to three of the company's key manufacturing facilities


The firm is in the process of preparing a response to the letter

Dr Reddy's Laboratories (DRL) has said that the US Food and Drug Administration (US FDA) has extended the time-frame for replying to the warning letter issued to the company by about two weeks to 7 December.

On November 5, 2015, the company has received a warning letter issued by the US health regulator relating to its API manufacturing facilities at Srikakulam, Andhra Pradesh and Miryalaguda, Telangana, as well as Oncology Formulation manufacturing facility at Duvvada, Visakhapatnam, Andhra Pradesh.

Dr Reddy's is in the process of preparing a response to FDA's warning letter. The FDA has granted an extension until December 7, 2015 for the submission of the Company's response to its warning letter.


Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box

National Health Policy

Is National Health Policy 2017 helpful for patients?

Send this article by email